Skip to main content

The independent medical news service

24-06-2020 | Oncology | Highlight | Article

Mental distress high among breast cancer patients during COVID-19 peak

Women with breast cancer had higher than normal levels of severe anxiety, depression, distress, and insomnia at the peak of the COVID-19 outbreak in the Hubei Province in China, study findings indicate.

22-06-2020 | Oncology | News | Article

Alpelisib positive opinion adopted for advanced PIK3CA-mutated breast cancer

Find out about this EMA decision here

12-06-2020 | Oncology | News | Article

PHOEBE shows PFS boost with pyrotinib in HER2-positive breast cancer

Combining pyrotinib instead of lapatinib with capecitabine is associated with significantly improved progression-free survival in patients who have received prior treatment for HER2-positive metastatic breast cancer, show phase 3 trial data.

11-06-2020 | Oncology | News | Article

No survival gain with early local therapy for de novo stage IV breast cancer

Individuals who present with metastatic breast cancer do not experience improvement in overall survival or other outcomes with early locoregional therapy for an intact primary tumor, according to ECOG-ACRIN 2108 trial findings.

08-06-2020 | Oncology | News | Article

Olaparib breast cancer activity not confined to patients with germline BRCA1/2 mutations

Findings from the proof-of-principle Olaparib Expanded study indicate that patients with stage IV breast cancer and germline PALB2 or somatic BRCA1/2 mutations may benefit from olaparib treatment.

04-06-2020 | Oncology | News | Article

Switching taxane–trastuzumab to T-DM1 shows no benefit in KAITLIN trial

Adjuvant treatment with trastuzumab emtansine does not improve outcome or reduce toxicity relative to that with a taxane plus trastuzumab in patients with HER2-positive early breast cancer, results of the phase 3 KAITLIN study show.

Image Credits